# American Assets Trust, Inc.: financial statements, quarterly

AAT · NYSE · CIK 1500217 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aat.md) · [Financials](/companies/aat/financials.md) · [Filings](/companies/aat/filings.md) · [Insiders](/companies/aat/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/aat/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [10.5](/filings/0001500217-24-000047.md) | [11.9](/filings/0001500217-24-000053.md) | [112](/filings/0001500217-25-000007.md) | [10.7](/filings/0001500217-25-000032.md) | [10.6](/filings/0001500217-25-000058.md) | [11.4](/filings/0001500217-25-000066.md) | [113](/filings/0001500217-26-000008.md) | [9.9](/filings/0001500217-26-000032.md) | [10.2](/filings/0001500217-25-000058.md) | [10.1](/filings/0001500217-25-000066.md) | [110](/filings/0001500217-26-000008.md) | [10.1](/filings/0001500217-26-000032.md) |
| Gross profit | $m | [69.9](/filings/0001500217-24-000047.md) | [69.9](/filings/0001500217-24-000053.md) | [68.8 d](/filings/0001500217-26-000008.md) | [69.6](/filings/0001500217-25-000032.md) | [70.5](/filings/0001500217-25-000058.md) | [80.4](/filings/0001500217-25-000066.md) | [69.6 d](/filings/0001500217-26-000008.md) | [67.3](/filings/0001500217-26-000032.md) | [67.6](/filings/0001500217-25-000058.md) | [66.3](/filings/0001500217-25-000066.md) | [65.4 d](/filings/0001500217-26-000008.md) | [66.9](/filings/0001500217-26-000032.md) |
| Operating income | $m | [31.5](/filings/0001500217-25-000007.md) | [31.1](/filings/0001500217-25-000007.md) | [29.4](/filings/0001500217-25-000007.md) | [30.5](/filings/0001500217-26-000008.md) | [30.8](/filings/0001500217-26-000008.md) | [37.8](/filings/0001500217-26-000008.md) | [30.0](/filings/0001500217-26-000008.md) | [72.0](/filings/0001500217-26-000032.md) | [26.0](/filings/0001500217-26-000008.md) | [24.8](/filings/0001500217-26-000008.md) | [23.2](/filings/0001500217-26-000008.md) | [25.8](/filings/0001500217-26-000032.md) |
| Interest expense | $m | [16.4 d](/filings/0001500217-23-000063.md) | [16.3 d](/filings/0001500217-23-000071.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.2](/filings/0001500217-24-000047.md) | [0.3](/filings/0001500217-24-000053.md) | [0.3 d](/filings/0001500217-26-000008.md) | [0.3](/filings/0001500217-25-000032.md) | [0.2](/filings/0001500217-25-000058.md) | [0.2](/filings/0001500217-25-000066.md) | [0.2 d](/filings/0001500217-26-000008.md) | [0.4](/filings/0001500217-26-000032.md) | [0.1](/filings/0001500217-25-000058.md) | [0.2](/filings/0001500217-25-000066.md) | [0.1 d](/filings/0001500217-26-000008.md) | [0.1](/filings/0001500217-26-000032.md) |
| Net income | $m | [12.0](/filings/0001500217-25-000007.md) | [11.8](/filings/0001500217-25-000007.md) | [10.5](/filings/0001500217-25-000007.md) | [19.3](/filings/0001500217-26-000008.md) | [11.9](/filings/0001500217-26-000008.md) | [16.7](/filings/0001500217-26-000008.md) | [9.0](/filings/0001500217-26-000008.md) | [42.5](/filings/0001500217-26-000008.md) | [5.5](/filings/0001500217-26-000008.md) | [4.5](/filings/0001500217-26-000008.md) | [3.1](/filings/0001500217-26-000008.md) | [6.7](/filings/0001500217-26-000032.md) |
| Diluted EPS | $ per share | [0.20](/filings/0001500217-25-000007.md) | [0.20](/filings/0001500217-25-000007.md) | [0.17](/filings/0001500217-25-000007.md) | [0.32](/filings/0001500217-26-000008.md) | [0.20](/filings/0001500217-26-000008.md) | [0.28](/filings/0001500217-26-000008.md) | [0.15](/filings/0001500217-26-000008.md) | [0.70](/filings/0001500217-26-000032.md) | [0.09](/filings/0001500217-26-000008.md) | [0.07](/filings/0001500217-26-000008.md) | [0.05](/filings/0001500217-26-000008.md) | [0.08](/filings/0001500217-26-000032.md) |
| Basic EPS | $ per share | [0.20](/filings/0001500217-25-000007.md) | [0.20](/filings/0001500217-25-000007.md) | [0.17](/filings/0001500217-25-000007.md) | [0.32](/filings/0001500217-26-000008.md) | [0.20](/filings/0001500217-26-000008.md) | [0.28](/filings/0001500217-26-000008.md) | [0.15](/filings/0001500217-26-000008.md) | [0.70](/filings/0001500217-26-000032.md) | [0.09](/filings/0001500217-26-000008.md) | [0.07](/filings/0001500217-26-000008.md) | [0.05](/filings/0001500217-26-000008.md) | [0.08](/filings/0001500217-26-000032.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [84.7](/filings/0001500217-23-000063.md) | [90.0](/filings/0001500217-23-000071.md) | [82.9](/filings/0001500217-25-000007.md) | [98.6](/filings/0001500217-24-000027.md) | [115](/filings/0001500217-24-000047.md) | [533](/filings/0001500217-24-000053.md) | [426](/filings/0001500217-26-000008.md) | [144](/filings/0001500217-25-000032.md) | [144](/filings/0001500217-25-000058.md) | [139](/filings/0001500217-25-000066.md) | [129](/filings/0001500217-26-000032.md) | [118](/filings/0001500217-26-000032.md) |
| Total assets | $m | [3,012](/filings/0001500217-23-000063.md) | [3,011](/filings/0001500217-23-000071.md) | [2,985](/filings/0001500217-25-000007.md) | [2,988](/filings/0001500217-24-000027.md) | [2,993](/filings/0001500217-24-000047.md) | [3,396](/filings/0001500217-24-000053.md) | [3,273](/filings/0001500217-26-000008.md) | [2,968](/filings/0001500217-25-000032.md) | [2,956](/filings/0001500217-25-000058.md) | [2,942](/filings/0001500217-25-000066.md) | [2,921](/filings/0001500217-26-000032.md) | [2,901](/filings/0001500217-26-000032.md) |
| Total liabilities | $m | [1,836](/filings/0001500217-23-000063.md) | [1,842](/filings/0001500217-23-000071.md) | [1,831](/filings/0001500217-25-000007.md) | [1,833](/filings/0001500217-24-000027.md) | [1,847](/filings/0001500217-24-000047.md) | [2,258](/filings/0001500217-24-000053.md) | [2,149](/filings/0001500217-26-000008.md) | [1,815](/filings/0001500217-25-000032.md) | [1,822](/filings/0001500217-25-000058.md) | [1,828](/filings/0001500217-25-000066.md) | [1,830](/filings/0001500217-26-000032.md) | [1,828](/filings/0001500217-26-000032.md) |
| Long-term debt | $m | not reported | not reported | [1,700](/filings/0001500217-24-000008.md) | not reported | not reported | not reported | [2,025](/filings/0001500217-25-000007.md) | not reported | not reported | not reported | [1,700](/filings/0001500217-26-000008.md) | not reported |
| Shareholders' equity | $m | [1,215](/filings/0001500217-23-000063.md) | [1,209](/filings/0001500217-23-000071.md) | [1,198](/filings/0001500217-25-000007.md) | [1,200](/filings/0001500217-24-000027.md) | [1,192](/filings/0001500217-24-000047.md) | [1,187](/filings/0001500217-24-000053.md) | [1,176](/filings/0001500217-26-000008.md) | [1,198](/filings/0001500217-25-000032.md) | [1,184](/filings/0001500217-25-000058.md) | [1,169](/filings/0001500217-25-000066.md) | [1,151](/filings/0001500217-26-000032.md) | [1,137](/filings/0001500217-26-000032.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [46.2 d](/filings/0001500217-24-000047.md) | [51.8 d](/filings/0001500217-24-000053.md) | [38.8 d](/filings/0001500217-26-000008.md) | [54.8](/filings/0001500217-25-000032.md) | [59.3 d](/filings/0001500217-25-000058.md) | [52.4 d](/filings/0001500217-25-000066.md) | [40.6 d](/filings/0001500217-26-000008.md) | [36.9](/filings/0001500217-26-000032.md) | [49.2 d](/filings/0001500217-25-000058.md) | [40.5 d](/filings/0001500217-25-000066.md) | [40.6 d](/filings/0001500217-26-000008.md) | [38.6](/filings/0001500217-26-000032.md) |
| Dividends paid | $m | [25.4 d](/filings/0001500217-24-000047.md) | [25.4 d](/filings/0001500217-24-000053.md) | [25.4 d](/filings/0001500217-26-000008.md) | [25.8](/filings/0001500217-25-000032.md) | [25.8 d](/filings/0001500217-25-000058.md) | [25.8 d](/filings/0001500217-25-000066.md) | [25.9 d](/filings/0001500217-26-000008.md) | [26.3](/filings/0001500217-26-000032.md) | [26.3 d](/filings/0001500217-25-000058.md) | [26.3 d](/filings/0001500217-25-000066.md) | [26.4 d](/filings/0001500217-26-000008.md) | [26.4](/filings/0001500217-26-000032.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [76.2](/filings/0001500217-23-000063.md) | [76.2](/filings/0001500217-23-000071.md) | [76.3](/filings/0001500217-24-000027.md) | [76.3](/filings/0001500217-24-000047.md) | [76.3](/filings/0001500217-24-000053.md) | [76.5](/filings/0001500217-25-000032.md) | [76.5](/filings/0001500217-25-000058.md) | [76.5](/filings/0001500217-25-000066.md) | [76.7](/filings/0001500217-26-000032.md) | [76.7](/filings/0001500217-25-000058.md) | [76.7](/filings/0001500217-25-000066.md) | [76.9](/filings/0001500217-26-000032.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 61,390,936 at 2026-05-01, from the cover of the [10-Q filed 2026-05-01](/filings/0001500217-26-000032.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.